As the world’s first antibiotic releasing bioabsorbable fixation device CiproScrew™ opens up new possibilities to prevent implant-related infections. CiproScrew™ releases an antimicrobial agent around itself inhibiting bacteria to colonize the surface of the screw, meanwhile being mechanically strong enough for fixation. Choose CiproScrew™ when your patient has an increased risk of infection.
CiproScrew™ is entirely compatible with AO-instrumentation.
No need for customized instrumentation!
CiproScrew™ is CE approved.
Not available in US market.
Benefits of using CiproScrew
- CiproScrew™ is indicated for fixation of bone fractures, osteotomies, arthrodeses, bone grafts and osteochondral fractures in the presence of appropriate immobilization when infection by ciprofloxacin sensitive organism is a potential risk.
- Risk group patients are smokers, alcoholics, immunocompromised patients such as aged people and diabetics, open fractures. In these cases treatment generally is extremely challenging, long lasting and very expensive.
Figure 1. Bacterial culture (S. aureus) on a Petri-dish with a metallic screw on the left (A) and CiproScrew™ on the right (B) after 18 hours incubation at 35°C. The antibiotic effect on the S. aureus culture can easily be seen as a clear ring around the CiproScrew™.
Surgical indications for CiproScrew™
- Ankle fractures
- Talar fractures
- Calcaneal fractures
- Hallux valgus surgery (Proximal osteotomy or TMT-I arthrodesis)
- Talocrural arthrodeses
- Subtalar arthrodeses
- Tibial condylar fractures
- Distal clavicular fracture
- Glenoid rim fractures
- Proximal humeral neck fractures
- Epiphyseolytic fractures in upper limb in children
- Lateral humeral condyle fractures
- Medial humeral condyle or epicondyle fractures
- Olecranon fractrures
- Distal radial fractures
- Hand fractures